C07K 16/303
Liver or pancreas
Official title: {Liver or Pancreas}
C07K16/303 (Liver or pancreas) appears on 519 US grants and 985 published applications in this corpus.
Search patents in C07K- Granted patents
- 519
- Published applications
- 985
- Assignees
- 393
- Inventors
- 1,757
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 2 | 0 |
| 1992 | 3 | 0 |
| 1993 | 1 | 0 |
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 2 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 4 | 1 |
| 2002 | 2 | 2 |
| 2003 | 1 | 5 |
| 2004 | 1 | 1 |
| 2005 | 1 | 14 |
| 2006 | 1 | 15 |
| 2007 | 3 | 17 |
| 2008 | 3 | 22 |
| 2009 | 5 | 18 |
| 2010 | 12 | 27 |
| 2011 | 19 | 36 |
| 2012 | 7 | 17 |
| 2013 | 15 | 24 |
| 2014 | 21 | 51 |
| 2015 | 30 | 60 |
| 2016 | 54 | 74 |
| 2017 | 37 | 93 |
| 2018 | 46 | 59 |
| 2019 | 41 | 63 |
| 2020 | 40 | 52 |
| 2021 | 35 | 52 |
| 2022 | 26 | 51 |
| 2023 | 25 | 55 |
| 2024 | 29 | 81 |
| 2025 | 20 | 52 |
| 2026 | 18 | 43 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Polypeptides comprising immunoglobulin single variable domains targeting Glypican-3 and T cell receptor18 Aug 2026US 12,709,646 B2Ablynx N. V.
- Enhanced chimeric antigen receptor cells in hypoxic tumor microenvironment18 Aug 2026US 12,709,737 B2Innovative Cellular Therapeutics Holdings, Ltd.
- Compositions and methods regarding engineered and non-engineered γδ T-cells for treatment of solid tumors4 Aug 2026US 12,698,340 B2Adicet Therapeutics, Inc.
- Functional antibody fragment complementation for a two-components system for redirected killing of unwanted cells7 Jul 2026US 12,673,993 B2Revitope Limited
- Protein containing heterodimer antibody Fc, and preparation method therefor7 Jul 2026US 12,673,996 B2Innovent Biologics (Suzhou) Co., Ltd.
- Methods and compositions for treating cancer1 Oct 2026US 2026/0297152 A1
- Car-t cell compositions, methods of use thereof1 Oct 2026US 2026/0297160 A1Augusta University Research Institute, Inc.
- Jaml transmembrane and co-signaling domains for chimeric antigen receptors24 Sep 2026US 2026/0284191 A1Kite Pharma, Inc.
- Humanized Anti-GPC-1 Antibody24 Sep 2026US 2026/0286004 A1Iwate Medical University
- Mirna for controlling expression of in vivo delivery constructs3 Sep 2026US 2026/0258413 A1CREATE Medicines, Inc.
Most cited
By later US patents
- Antitumor protein hybrid and process for the preparation thereof135US 4,379,145 AHidematsu Hirai · 1983
- Database for storage and analysis of full-length sequences121US 6,303,297 B1Incyte Pharmaceuticals, Inc. · 2001
- Immunoconjugates with an intracellularly-cleavable linkage115US 7,999,083 B2Immunomedics, Inc. · 2011
- Immunoconjugates with an intracellularly-cleavable linkage85US 8,080,250 B1Immunomedics, Inc. · 2011
- Antibodies specific for Trop-2 and their uses72US 8,871,908 B2Rinat Neuroscience Corp. · 2014